Lori Raney, MD, principal, Health Management Associates, provided a definition and examples of integrated care for physical and behavioral health, in addition to explaining the strengths of the collaborative care model.
Lori Raney, MD, principal, Health Management Associates, provided a definition and examples of integrated care for physical and behavioral health, in addition to explaining the strengths of the collaborative care model.
Transcript
How would you define integrated care, and what are some examples?
Integrated care is when you design a healthcare system to address the physical health and the behavioral health of a particular patient or in a particular patient population. We talk a lot about the integration of behavioral health into primary care settings, but we also talk about integrating primary care into behavioral health settings so that we get whole-person care.
Other examples would be addressing behavioral health conditions in intensive care units, on medical/surgical inpatient units, in emergency rooms, and in other clinics, but mostly what you’ll hear people talking about when they mention integrated care is really thinking about addressing behavioral health in primary care settings.
What is the collaborative care model and how can it deliver evidence-based behavioral health care?
The collaborative care model is a very robust model of integrating primary care and behavioral health, primarily in the primary care setting. In this model, behavioral care managers, who are typically licensed social workers, psychologists, therapists, work with the primary care provider and the patient to come up with a treatment plan to address their behavioral health conditions. Supporting that is the work of a psychiatric consultant, so they’re reviewing the patient’s care, their treatment plan, and making suggestions to the primary care provider for how to change or intensify or adjust their treatment if they’re not getting better.
The model really works off some core principles, such as measurement-based treatment to target, so we are able to treat someone’s depression to remission, to clinical improvement, just as we would with something like diabetes.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More